KIMBERLEY DEATS: Open Payments
NPI 1518078260 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 12 payments from 5 companies in 2025. Trend: 2023 $411 · 2024 $151 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| MIMEDX Group, Inc. | 4 | $55 |
| UCB, Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| ABBVIE INC. | 2 | $29 |
Products named: Bimzelx, COSENTYX, Sotyktu, SKYRIZI.
Industry payments across NE — which companies pay providers there.
